Alfuzosin Hydrochloride
- Product NDC
- 70934-961
- 11-digit product format
- 709340961
- Labeler code
- 70934
- Product ID
- 70934-961_f05746fd-7f63-77ac-e053-2a95a90aece8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA090284
- Marketing category
- ANDA
- Marketing start
- 2022-03-23
- Marketing end
- 2023-05-31
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-961-30 | 70934096130 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-961-30) | 30 tablet | 2022-03-23 | 0000-00-00 | No | No | Current |